Guardant Health Inc (GH) Stock Price & News

Why is GH up 2.94%?

Dive Deeper

GH:NASDAQ

Guardant Health Inc

$ 159.91

+2.94%

(+4.56) 1D

11-р сарын 11, 09:55:57 (GMT-5) · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for GH...

Open

$ 157.11

High

$ 163.39

Low

$ 157.11

Mkt. cap

21.63 тэрбум

Avg. vol.

2.08 сая

Volume

142.37 мян

52-wk high

$ 191.01

52-wk low

$ 74.55

EPS

-$ 3.68

Beta

1.67

Shares outstanding

135.29 сая

No. of employees

2 мян

Open

$ 157.11

High

$ 163.39

Low

$ 157.11

Mkt. cap

21.63 тэрбум

Avg. vol.

2.08 сая

Volume

142.37 мян

52-wk high

$ 191.01

52-wk low

$ 74.55

EPS

-$ 3.68

Beta

1.67

Shares outstanding

135.29 сая

No. of employees

2 мян

Related stocks

News stories

From web sources and news partners

Seeking Alpha

15 цагийн өмнө

Guardant Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:GH) 2026-11-10

Trefis

1 өдрийн өмнө

What Sent Guardant Health Stock Higher?

Yahoo Finance

2 өдрийн өмнө

GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability

Profile

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia

About Guardant Health Inc

CEOHelmy Eltoukhy | AmirAli Talasaz

Employees2.5 мян

Founded2012

HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс

SectorHealth Care

IndustryHealth care provider

Websiteguardanthealth.com

Analyst ratings

Based on 19 analysts giving stock ratings to GH in the past 3 months

Strong buy

Buy

Hold

Sell

12-month forecast

Based on 19 Wall Street analysts offering 12 month price targets for GH in the last 3 months.

Highest

Current $ 159.91

$ 225.00 (+40.70%)

Average

$ 204.00 (+27.57%)

Lowest

$ 180.00 (+12.56%)

Analyst	Recommendation	Action	Price target	Projected	Date
David Westenberg Piper Sandler	Buy	Reiterated	$ 190.00	+18.8%	11/10/2026
Lu Li Bank of America Securities	Buy	Maintained	-	-	11/06/2026
Daniel Arias Stifel Nicolaus	Buy	Maintained	$ 180.00	+12.6%	11/06/2026
Evie Koslosky Goldman Sachs	Buy	Maintained	$ 210.00	+31.3%	11/06/2026
Kyle Mikson CFA Canaccord Genuity	Buy	Reiterated	$ 205.00	+28.2%	11/06/2026
Dan Leonard RBC Capital	Buy	Maintained	$ 200.00	+25.1%	11/06/2026
Daniel Brennan TD Cowen	Buy	Maintained	$ 220.00	+37.6%	11/06/2026
Catherine Ramsey Schulte Robert W. Baird	Buy	Maintained	$ 196.00	+22.6%	11/06/2026
Luke Sergott Barclays	Buy	Maintained	$ 220.00	+37.6%	11/06/2026
Mark Massaro BTIG	Buy	Maintained	$ 210.00	+31.3%	10/27/2026
Max Masucci Roth MKM	Buy	Initiated	$ 200.00	+25.1%	10/22/2026
Kallum Titchmarsh Morgan Stanley	Buy	Maintained	$ 200.00	+25.1%	10/20/2026
Eve Burstein Bernstein	Buy	Reiterated	$ 210.00	+31.3%	10/19/2026
Casey Woodring J.P. Morgan	Buy	Maintained	$ 195.00	+21.9%	10/14/2026
Michael Ryskin Bank of America Securities	Buy	Maintained	$ 200.00	+25.1%	10/09/2026
Subbu Nambi Guggenheim	Buy	Maintained	$ 200.00	+25.1%	10/01/2026
William Bonello Craig-Hallum	Buy	Maintained	-	-	09/15/2026
Unknown Analyst UBS	Buy	Maintained	$ 225.00	+40.7%	09/09/2026
Doug Schenkel UBS	Buy	Maintained	$ 225.00	+40.7%	09/09/2026
Jamie Clark Rothschild & Co Redburn	Buy	Initiated	$ 203.00	+26.9%	09/08/2026
Matt Larew William Blair	Buy	Maintained	-	-	09/08/2026
Bradley Bowers Mizuho Securities	Buy	Maintained	$ 200.00	+25.1%	08/04/2026
Mason Carrico Stephens	Buy	Maintained	$ 195.00	+21.9%	08/04/2026
Brandon Couillard Wells Fargo	Buy	Maintained	$ 125.00	-21.8%	07/29/2026
Patrick B Donnelly Citi	Buy	Maintained	$ 215.00	+34.5%	07/08/2026
Vijay Kumar Evercore ISI	Buy	Maintained	$ 200.00	+25.1%	07/06/2026
Puneet Souda Leerink Partners	Buy	Reiterated	-	-	06/02/2026
Paige Chamberlain‏ Wolfe Research	Buy	Reiterated	$ 150.00	-6.2%	06/01/2026
Unknown Analyst Wolfe Research	Buy	Reiterated	$ 150.00	-6.2%	06/01/2026
Andrew Brackmann William Blair	Buy	Maintained	-	-	05/27/2026
Andrew Cooper Raymond James	Buy	Reiterated	$ 129.00	-19.3%	02/23/2026

All values in USD	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар	2026 оны 9-р сар
Revenue	281.27 сая	301.66 сая	334.98 сая	360.98 сая
Cost of goods sold	99.49 сая	104.92 сая	115.95 сая	124.82 сая
Cost of revenue	99.49 сая	104.92 сая	115.95 сая	124.82 сая
Research and development expenses	98.26 сая	91.04 сая	96.53 сая	100.84 сая
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	204.20 сая	227.06 сая	250.61 сая	269.08 сая
Operating expense	302.46 сая	318.10 сая	347.15 сая	369.92 сая
Total operating expenses	401.96 сая	423.02 сая	463.10 сая	494.74 сая
Operating income	-120.69 сая	-121.35 сая	-128.12 сая	-133.76 сая
Other non operating income	-4.69 сая	1.55 сая	308.00 мян	342.00 мян
EBT including unusual items	-130.22 сая	-111.70 сая	-119.96 сая	-124.02 сая
EBT excluding unusual items	-116.52 сая	-111.70 сая	-118.96 сая	-125.02 сая
Income tax expense	-1.73 сая	372.00 мян	185.00 мян	343.00 мян
Effective tax rate	1.33%	-0.33%	-0.15%	-0.28%
Other operating expenses	-	-	-	-
Net income	-128.49 сая	-112.08 сая	-120.14 сая	-124.36 сая
Net profit margin	-45.68%	-37.15%	-35.87%	-34.45%
Earnings per share	-0.50	-0.45	-0.42	-0.29
Interest and investment income	10.03 сая	11.15 сая	10.20 сая	9.75 сая
Interest expense	-1.18 сая	-3.05 сая	-1.35 сая	-1.34 сая
Net interest expenses	8.85 сая	8.10 сая	8.85 сая	8.40 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	-110.64 сая	-111.91 сая	-118.56 сая	-123.59 сая
Gain or loss from assets sale	-	-	-	-

Ask anything